Avelumab - National Cancer Institute
Avelumab, sold under the brand name Bavencio, is a fully human monoclonal antibody medication for the treatment of Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Common side effects include fatigue, musculoskeletal pain, diarrhea, nausea, infusion-related reactions, rash, decreased appetite and swelling of the limbs (peripheral edema). Avelumab targets the protein programmed death-ligand 1 (PD-L1). It has received orphan drugde…
Images Of Avelumab
Avelumab is a type of immunotherapy called a checkpoint inhibitor. This type of treatment stimulates the body’s immune system to fight cancer cells. Avelumab targets and blocks a protein called PD-L1 on the surface of certain immune cells. Blocking PD-L1 activates the immune cells to find and kill cancer cells.
Explore
Avelumab | Cancer information | Cancer Research UK
Avelumab - Wikipedia
Avelumab - Drug Information - Chemocare
Avelumab | Cancer Information | Cancer Research UK
Avelumab - Wikipedia
Avelumab (BAVENCIO) | FDA
Avelumab - National Cancer Institute
Avelumab - Drug Information - Chemocare
Avelumab is a programmed death-ligand 1 (PD-L1) blocking human IgG1 lambda monoclonal antibody. This is the first FDA-approved product to treat this type of cancer. Approval was based on data from ...
Videos Of Avelumab
Avelumab is the generic name for the trade name drug Bavencio®. In some cases, health care professionals may use the trade name Bavencio® when referring to the generic drug name avelumab. Drug Type: Avelumab is an anti-PD-L1 monoclonal antibody. (For more detail, see "How Avelumab Works" below). What Avelumab Is Used For
BAVENCIO® (avelumab) | For Healthcare Professionals
Avelumab (BAVENCIO) maintenance is the only NCCN CATEGORY 1 and PREFERRED immunotherapy option for both cisplatin-eligible and -ineligible patients with locally advanced or metastatic UC that has not progressed on first-line platinum-containing chemotherapy. 1. Category 1=Based upon high-level evidence, there is uniform NCCN consensus that the …
Avelumab Uses, Side Effects & Warnings - Drugs.com
12/01/2021 · Avelumab side effects. Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.. Some side effects may occur during the injection. Tell your caregiver right away if you feel light-headed, itchy, feverish, chilled, or have stomach or back pain, trouble breathing, or flushing (warmth, …
FDA Approves Avelumab For Urothelial Carcinoma …
01/07/2020 · The recommended avelumab dose is 800 mg administered as an intravenous infusion over 60 minutes every 2 weeks until disease progression or unacceptable toxicity. The results from this study ...
Activity And Tolerability Of Maintenance Avelumab …
Patients will receive Avelumab injections 10mg/ kg every two weeks until progression or unacceptable toxicity. The primary endpoint will be the progression free survival (PFS) according to RECIST v1.1 criteria. Secondary endpoints will include PFS according to iRECIST criteria, overall survival, quality of life, safety. Ancillary explorations will include assessing blood and …